Literature DB >> 20042682

Influence of Hoxa5 on p53 tumorigenic outcome in mice.

Gaëlle Gendronneau1, Margot Lemieux, Mélanie Morneau, Josée Paradis, Bernard Têtu, Nancy Frenette, Josée Aubin, Lucie Jeannotte.   

Abstract

Hox genes encode transcription factors of crucial importance in the pattern formation of a large spectrum of species. Several studies have now proposed a role for these developmental genes in cancer biology. It has been suggested that HOXA5 possesses growth-suppressive properties through activation of p53 expression in human breast tissue. To assess the genetic cooperation that may exist between Hoxa5 and p53 in tumorigenesis, we generated Hoxa5/p53 compound mutant mice. The presence of Hoxa5 null alleles increased the susceptibility of p53(-/-) mice to develop tumors with a high prevalence for thymic lymphoma, suggesting that the loss of function of the two genes collaborate in tumor formation. To extend our analysis to mammary tumorigenesis, we performed Hoxa5/p53 whole mammary gland transplantations into wild-type hosts. In the p53(-/-) background, the presence of one Hoxa5 mutant allele had no impact on mammary tumor formation. In contrast, the complete loss of Hoxa5 function influenced the tumorigenic outcome of p53(+/-) mammary glands. However, the collaborative nature of this interaction did not depend on the transcriptional regulation of p53 by Hoxa5. Altogether, our data establish that Hoxa5 and p53 cooperate in mammary tumorigenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042682      PMCID: PMC2808102          DOI: 10.2353/ajpath.2010.090499

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Homeobox genes: molecular link between congenital anomalies and cancer.

Authors:  R Anbazhagan; V Raman
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

2.  Analysis of beta 2-microglobulin gene expression in the developing mouse embryo and placenta.

Authors:  L Jaffe; L Jeannotte; E K Bikoff; E J Robertson
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

Review 3.  Deregulated homeobox gene expression in cancer: cause or consequence?

Authors:  Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

4.  HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells.

Authors:  Micheline C Chu; F Belgin Selam; Hugh S Taylor
Journal:  Cancer Biol Ther       Date:  2004-06-15       Impact factor: 4.742

5.  Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

Authors:  C Kuperwasser; G D Hurlbut; F S Kittrell; E S Dickinson; R Laucirica; D Medina; S P Naber; D J Jerry
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

Authors:  R D Cardiff; M R Anver; B A Gusterson; L Hennighausen; R A Jensen; M J Merino; S Rehm; J Russo; F A Tavassoli; L M Wakefield; J M Ward; J E Green
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

7.  Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.

Authors:  Anneke C Blackburn; S Christine McLary; Rizwan Naeem; Jason Luszcz; David W Stockton; Lawrence A Donehower; Mansoor Mohammed; John B Mailhes; Tamar Soferr; Stephen P Naber; Christopher N Otis; D Joseph Jerry
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

8.  Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice.

Authors:  Dominique Meunier; Josée Aubin; Lucie Jeannotte
Journal:  Dev Dyn       Date:  2003-07       Impact factor: 3.780

9.  HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8.

Authors:  Hexin Chen; Seung Chung; Saraswati Sukumar
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

10.  Stomach regional specification requires Hoxa5-driven mesenchymal-epithelial signaling.

Authors:  Josée Aubin; Ugo Déry; Margot Lemieux; Pierre Chailler; Lucie Jeannotte
Journal:  Development       Date:  2002-09       Impact factor: 6.868

View more
  12 in total

1.  The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.

Authors:  Gaëlle Gendronneau; Olivier Boucherat; Josée Aubin; Margot Lemieux; Lucie Jeannotte
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 2.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

3.  Enforced expression of Hoxa5 in haematopoietic stem cells leads to aberrant erythropoiesis in vivo.

Authors:  Dan Yang; Xiangzhong Zhang; Yong Dong; Xiaofei Liu; Tongjie Wang; Xiaoshan Wang; Yang Geng; Shumin Fang; Yi Zheng; Xiaoli Chen; Jiekai Chen; Guangjin Pan; Jinyong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  MicroRNA 196B Regulates HOXA5, HOXB6 and GLTP Expression Levels in Colorectal Cancer Cells.

Authors:  Ji-Su Mo; Young-Ran Park; Soo-Cheon Chae
Journal:  Pathol Oncol Res       Date:  2018-03-12       Impact factor: 3.201

5.  Multiple promoters and alternative splicing: Hoxa5 transcriptional complexity in the mouse embryo.

Authors:  Yan Coulombe; Margot Lemieux; Julie Moreau; Josée Aubin; Milan Joksimovic; Félix-Antoine Bérubé-Simard; Sébastien Tabariès; Olivier Boucherat; François Guillou; Christian Larochelle; Christopher K Tuggle; Lucie Jeannotte
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

6.  MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.

Authors:  Xiang-hua Liu; Kai-hua Lu; Ke-ming Wang; Ming Sun; Er-bao Zhang; Jin-song Yang; Dan-dan Yin; Zhi-li Liu; Jing Zhou; Zhi-jun Liu; Wei De; Zhao-xia Wang
Journal:  BMC Cancer       Date:  2012-08-09       Impact factor: 4.430

7.  p53 Is Not Required for High CIN to Induce Tumor Suppression.

Authors:  Laura C Funk; Jun Wan; Sean D Ryan; Charanjeet Kaur; Ruth Sullivan; Avtar Roopra; Beth A Weaver
Journal:  Mol Cancer Res       Date:  2020-09-18       Impact factor: 6.333

8.  HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.

Authors:  Chi-Jen Chang; Yen-Lin Chen; Chia-Hung Hsieh; Ya-Jung Liu; Sung-Liang Yu; Jeremy J W Chen; Chi-Chung Wang
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

9.  HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer.

Authors:  Clara Yuri Kim; Yu Cheon Kim; Ji Hoon Oh; Myoung Hee Kim
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

10.  Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.

Authors:  Swapna Asuthkar; Victoria Stepanova; Tatiana Lebedeva; Aixuan L Holterman; Norman Estes; Douglas B Cines; Jasti S Rao; Christopher S Gondi
Journal:  Mol Biol Cell       Date:  2013-07-17       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.